16 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, for example, because of differences in raw materials or manufacturing processes. For such products, the results of appropriate preclinical or clinical trials … authorities. While we will continue to source raw materials from external CMOs, we plan to make the transition from external CMOs to our manufacturing
6-K
EX-99.1
AUTL
Autolus Therapeutics plc
5 Aug 21
Index to Condensed Consolidated Financial Statements
4:04pm
The decrease in accruals of $4.0 million in research and development costs is related to usage of the accruals for raw materials and services for clinical
6-K
EX-1
AUTL
Autolus Therapeutics plc
30 Jun 21
Annual Report and Accounts
6:05am
but that do not meet the definition of a generic medicinal product, for example, because of differences in raw materials or manufacturing processes
6-K
EX-1
bvt4r2u
26 May 20
Current report (foreign)
4:31pm
20-F
gjddrp0nd6s41
23 Nov 18
Annual report (foreign)
12:00am
424B4
ytdjf gwnz
22 Jun 18
Prospectus supplement with pricing info
4:02pm
F-1/A
c3470l7siu3021
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-1/A
009me3ro4wqpiwwe
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
EX-10.2
7t8c9d65
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
EX-10.2
s1r8nb
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1/A
pjuixx ikzkbx
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1
6sfrwn5 tl6y3t
7 May 18
Registration statement (foreign)
4:45pm
F-1
EX-10.2
v23oha7c feoco3mlws
7 May 18
Registration statement (foreign)
4:45pm
- Prev
- 1
- Next